These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 151636)

  • 1. Lymphoblastogenesis in Down's syndrome and its inhibition by human interferon.
    Gurari-Rotman D; Revel M; Tartakovsky B; Segal S; Hahn T; Handzel Z; Levin S
    FEBS Lett; 1978 Oct; 94(2):187-90. PubMed ID: 151636
    [No Abstract]   [Full Text] [Related]  

  • 2. An apparently immunoregulatory effect of human leukocyte interferon on the blastogenic response in Down's syndrome.
    Hahn T; Levin S; Handzel ZT; Ashkenazi A; Chemke J; Shterk V
    Isr J Med Sci; 1979 Sep; 15(9):775-8. PubMed ID: 159876
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of human interferon preparations on lymphoblastogenesis in Down's syndrome.
    Cupples CG; Tan YH
    Nature; 1977 May; 267(5607):165-7. PubMed ID: 16073432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing effect of lithium and potassium ions on lectin-induced lymphocyte proliferation in aging and Down's syndrome subjects.
    Licastro F; Chiricolo M; Tabacchi P; Barboni F; Zannotti M; Franceschi C
    Cell Immunol; 1983 Jan; 75(1):111-21. PubMed ID: 6297805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-lymphocyte function and sensitivity to interferon in trisomy 21.
    Epstein LB; Epstein CJ
    Cell Immunol; 1980 May; 51(2):303-18. PubMed ID: 6154538
    [No Abstract]   [Full Text] [Related]  

  • 6. T and B lypmhocyte subpopulations in Down's syndrome. A study on non-institutionalised subjects.
    Franceschi C; Licastro F; Paolucci P; Masi M; Cavicchi S; Zannotti M
    J Ment Defic Res; 1978 Sep; 22(3):179-91. PubMed ID: 151743
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of human leukocyte interferon on the response of lymphocytes to mitogenic stimuli in vitro.
    Blomgren H; Strander H; Cantell K
    Scand J Immunol; 1974; 3(6):697-705. PubMed ID: 4281930
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytogenetic observations in cultured lymphocytes from patients with Down's syndrome and measles.
    Higurashi M; Tamura T; Nakatake T
    Pediatr Res; 1973 Jun; 7(6):582-7. PubMed ID: 4267765
    [No Abstract]   [Full Text] [Related]  

  • 9. Down's syndrome as a model disease.
    Scoggin CH; Patterson D
    Arch Intern Med; 1982 Mar; 142(3):462-4. PubMed ID: 6461305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired in vitro response of circulating lymphocytes to phytohemagglutinin in Down's syndrome: dose- and time-response curves and relation to cellular immunity.
    Rigas DA; Elsasser P; Hecht F
    Int Arch Allergy Appl Immunol; 1970; 39(5-6):587-608. PubMed ID: 4250088
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocyte proliferation in Down's syndrome measured by sister chromatid differential staining.
    Crossen PE; Morgan WF
    Hum Genet; 1980; 53(3):311-3. PubMed ID: 6154638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down's syndrome: establishment of lymphoblastoid cell lines with trisomy 21.
    Miyoshi I; Yoshimoto S; Fujiwara S; Kiraki K; Kimura S
    Cancer; 1974 Mar; 33(3):739-42. PubMed ID: 4361078
    [No Abstract]   [Full Text] [Related]  

  • 13. T cell response to anti-CD3 antibody in Down's syndrome.
    Bertotto A; Arcangeli C; Crupi S; Marinelli I; Gerli R; Vaccaro R
    Arch Dis Child; 1987 Nov; 62(11):1148-51. PubMed ID: 2961309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fluorescence polymorphism associated with Down's syndrome?
    Robinson JA; Newton M
    J Med Genet; 1977 Feb; 14(1):40-5. PubMed ID: 138745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of priming on interferon inhibition of con A induced spleen cell blastogenesis.
    Rozes KR; Lee SH; Ngan J
    Nat New Biol; 1973 Sep; 245(140):16-8. PubMed ID: 4516936
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunodeficiency in Down's syndrome: analysis by OKT monoclonal antibodies.
    Bertotto A; Gerli R; Fabietti G; Arcangeli CD; Bianchi S; Vaccaro R
    Thymus; 1984; 6(6):365-7. PubMed ID: 6084348
    [No Abstract]   [Full Text] [Related]  

  • 17. [Satellite chromosome associations in normal humans and in Down's syndrome].
    Zhdanova NS
    Tsitologiia; 1971 Jan; 13(1):42-50. PubMed ID: 4253662
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of children with Down's syndrome.
    Dobrzanska A
    Pol Med Sci Hist Bull; 1970 Jan; 13(1):8-14. PubMed ID: 4244370
    [No Abstract]   [Full Text] [Related]  

  • 19. Distinguishing between the chromosomes involved in Down's syndrome (trisomy 21) and cronic myeloid leukaemia (Ph1) by fluorescence.
    O'Riordan ML; Robinson JA; Buckton KE; Evans HJ
    Nature; 1971 Mar; 230(5290):167-8. PubMed ID: 4100531
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunity in Down's syndrome.
    Burgio GR; Ugazio AG
    Eur J Pediatr; 1978 Apr; 127(4):293-4. PubMed ID: 149663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.